Eduard Vieta - Selected Publications#

Google scholar H-index 140 (77,270 citations, i10-index 840)

1) Taipale H, Schneider-Thoma J, Pinzón-Espinosa J, et al. Representation and Outcomes of Individuals With Schizophrenia Seen in Everyday Practice Who Are Ineligible for Randomized Clinical Trials. JAMA Psychiatry. 2022 Jan 26:e213990. doi: 10.1001/jamapsychiatry. 2021.3990.

A very recent paper providing insights on the balance between internal and external validity ion clinical trials.

2) Crovetto F, Crispi F, Casas R, Martín-Asuero A, Borràs R, Vieta E, et al. IMPACT BCN Trial Investigators. Effects of Mediterranean Diet or Mindfulness-Based Stress Reduction on Prevention of Small-for-Gestational Age Birth Weights in Newborns Born to At-Risk Pregnant Individuals: The IMPACT BCN Randomized Clinical Trial. JAMA. 2021 Dec 7;326(21):2150-2160.

An outstanding contribution showing the efficiacy of the first evidence-based therapies for newborns at risk of small-for gestational age through their mothers. The candidate role was to design the psychosocial intervention and trial design.

3) Abé C, Ching CRK, Liberg B, et al. ENIGMA Bipolar Disorder Working Group. Longitudinal Structural Brain Changes in Bipolar Disorder: A Multicenter Neuroimaging Study of 1232 Individuals by the ENIGMA Bipolar Disorder Working Group. Biol Psychiatry. 2021 Sep 16:S0006-3223(21)01597-3.

First longitudinal study on the neuroprogression of structural anomalies in the brain of bipolar patients.

4) Vieta E, Alonso J, Pérez-Sola V, Roca M, Hernando T, Sicras-Mainar A, et al. Epidemiology and costs of depressive disorder in Spain: the EPICO study. Eur Neuropsychopharmacol. 2021 Sep;50:93-103.

A large epidemiologic study on the prevalence and costs associated to major depression.

5) Mullins N, Forstner AJ, O'Connell KS, et al. Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. Nat Genet. 2021 Jun;53(6):817-829.

Largest study ever on the genetics of bipolar disorder.

6) Moreno C, Wykes T, Galderisi S, Nordentoft M, Crossley N, Jones N, et al. How mental health care should change as a consequence of the COVID-19 pandemic. Lancet Psychiatry 2020;7(9):813-824.

Highly cited paper on the impact of the Covid-19 pandemic on mental health and potential solutions.

7) Carvalho AF, Firth J, Vieta E. Bipolar Disorder. N Engl J Med. 2020 Jul 2;383(1):58-66.

A crisp, evidence based update published in one of the most influential scientific journals.

8) Lee PH, Anttila V, Won H, Feng Y-A, Rosenthal J, Zhu Z, et al. Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders. Cell 2019;179(7):1469-1482.e11.

An outstanding contribution to the crossroads of 8 major psychiatric conditions sharing genetic vulnerability.

9) Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord 2018;20(2):97-170.

An update of one of the most influential treatment guidelines for bipolar disorder with the candidate as representative of the European view.

10) Vieta E, Berk M, Schulze TG, Carvalho AF, Suppes T, Calabrese JR, Gao K, Miskowiak KW, Grande I. Bipolar disorders. Nat Rev Dis Primers. 2018 Mar 8;4:18008.

A prestigious contribution under the candidate leadership dealing with the neurobiology of bipolar disorder.